Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
Christenson RH, Cervelli DR, Sterner J, Bachmann LM, Rebuck H, Gray J, Kelley WE
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to evaluate the effects of anticoagulant, storage, and assay type on the measurement of cancer biomarkers in blood.
Summary of Findings
For the Dimension VISTA assay, the type of anticoagulant used had no effects on the measurement of CA 15-3, CA19-9, CA 125 II, AFP or CEA. After storage for 12 months at -70 degrees C or -20 degrees C, more than 90% of CA 15-3 and CA 19-9 was recovered from serum, lithium heparin-plasma, sodium heparin-plasma and 4 of 5 EDTA specimens, the fifth one having 81% of CA 19-9 recovered. After storage for 9 months at -70 degrees C, more than 90% of CA 125 II was recovered from serum and plasma, regardless of anticoagulant; however, after 9 months of storage at -20 degrees C, only 89% of CA 125 was recovered from lithium heparin specimens, but more than 90% of CA 125 was recovered with all other anticoagulants. After storage of serum or lithium heparin specimens for 7 days at 4 degrees C or 7 or 120 days at -20 degrees C, more than 93.7% of AFP was recovered. CEA recovery was greater than 96.7% for specimens stored for 7 days at any temperature and greater than 98.6% for specimens stored at -20 or -70 degrees C. CEA was lower in non-smokers than in smokers. A high degree of correlation was found between the Dimension VISTA and other analyzers during the course of patient treatment. Overall expression level patterns agreed for CA 15-3, CA 19-9, CA 125 II, AFP and CEA in 89% of breast cancer, 92% of pancreatic cancer, 98% ovarian cancer, 90% of testicular cancer and 94% of colorectal cancer specimens, respectively. Lot to lot correlation between reagents on the Dimension Vista was high.
Biospecimens
FluidBloodFluidPlasmaFluidSerumPreservation Types
None (Fresh)FrozenDiagnoses
NeoplasticCarcinomaNeoplasticPlatforms
ProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTALithium heparinNoneSodium heparinBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Storage duration 0 days12 months120 days7 days9 monthsStorage Storage temperature -20 degrees C-70 degrees C4 degrees CClinical chemistry/auto analyzer Specific Detection method Lot 1Lot 2Clinical chemistry/auto analyzer Specific Technology platform ADVIA CentaurAbbott AxSymBeckmann AccessDimension VISTA